Partner Content

How an innovative new bioreactor is using ultra-fine filters to increase T-cell production

Cell cultivation is labour-intensive and includes many open process steps requiring expensive cleanroom procedures once the transition to clinical production…

How to cut drug supply costs with seamless forecasting and IRT systems

An accurate drug supply forecast is essential for a successful clinical trial. Without it, sponsors risk a shortage of investigative…

What’s next for Container Closure Integrity Testing?

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating…

How remote monitoring tech is enhancing healthcare for ageing populations

A growing ageing population presents many challenges for health services globally that are already buckling under the strain of recovering…

Reinventing the drum: How milling innovations are cutting costs and reducing footprints

All evidence indicated that containment in facilities is in high demand and will be increasingly so in the future as…

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic

Understanding how a drug will act in the body, including how it is absorbed, distributed, and eventually eliminated, is a…

A guide to managing hazardous waterborne bacteria outbreaks

An outbreak of hazardous bacteria can happen in any healthcare facility, even with preventative measures in place. When an outbreak…

Race is on to claim share of biomanufacturing market

Innovations in biotechnology are advancing the biopharmaceutical market, enabling the treatment of complex diseases with next-generation therapeutics synthesised or extracted…

Lab to jab in 100 days: manufacturing flexibility for future rapid responses

Vaccines are our number one weapon in the fight against infectious diseases, but their development has historically involved a long…

How API CMOs can improve containment capabilities without facility acquisition

According to GlobalData analysis, specialist small molecule API capabilities such as containment or controlled substances are driving large contract manufacturing…

Under the hood: Mapping the Future of Electric Vehicles in Data

Countries around the world are scaling up new technologies and releasing policy plans with the ambition of reaching net zero…

Enabling access continuity of medical treatments for patients

Many factors can lead to a patient losing access to medication, including the end of their clinical trial, having products…

Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with…

War in Ukraine: What it means for clinical trial operations

Russia’s full-scale invasion of Ukraine in February has had local, regional and global ramifications for clinical trial operations. Alongside its…

The new technologies strengthening pharmaceutical supply chains

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial…